Patent: Difference between revisions
imported>Robert Badgett |
imported>Stan Protigal (→United States: added sub-section heading to existing "term extn." text. This will facilitate adding add'l material on extension for USPTO administrative delay (typically 0 days to about 2 years) which inventors occasionally see.) |
||
| Line 14: | Line 14: | ||
* 20 years for patents issued after June 8, 1995 | * 20 years for patents issued after June 8, 1995 | ||
====Patent term extensions==== | |||
Patents for products such as food additives and drugs that require approval by federal entities such as the US [[Food and Drug Administration]] prior to marketing, can have a maximum of 5 years extended to the patent to compensate for marketing time lost while waiting for approval."<ref>[https://www.uspto.gov/web/offices/pac/mpep/s2750.html MPEP 2750 Patent Term Extension for Delays at other Agencies under 35 U.S.C. 156</ref> In all cases, the total patent life for the product with the patent extension cannot exceed 14 years from the product’s approval date, or in other words, 14 years of potential marketing time. "<ref name="urlPatent Term Restoration"/><ref name="urlwww.fda.gov">{{cite web |url=http://www.fda.gov/bbs/topics/speech/spe00001.htm |title= Statement by Stuart Nightingale, M.D. Associate Commissioner For Health Affairs U.S. Food and Drug Administration Public Health Service Department Of Health And Human Services Before the Subcommittee on Patents, Copyrights and Trademarks Committee on the Judiciary United States Senate |author=Nightingale, S |authorlink= |coauthors= |date=August 1, 1991 |format= |work= |publisher=US Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-01-11}}</ref> | |||
== Forms of patent infringement == | == Forms of patent infringement == | ||
Revision as of 21:59, 2 June 2018
A patent is an exclusive right or set of exclusive rights granted to a patentee by a state, in exchange for the public disclosure of specific details of an "invention". The exact exclusive right(s) differ in different countries, but in most countries a patent results in protection in two distinct fields. On the one hand it grants protection against unauthorised use of the invention. Which means in theory any use, such as renting, selling, researching or production, of the patent can be restricted or prevented in the country where the invention is patented. On the other hand it grants protection of the technical aspects of the patent. Which means the invention itself, and the production process to produce the invention, are protected. Both the unauthorised production and unauthorised use of a patent can result in patent infringement.
In the United States, the Patent Act allows patents of four categories: process, machine, manufacture, or composition of matter.[1]
Extent of patent protection
The extent of protection granted through a patent,what is and what is not protected through a patent, is dependent on the interpretation one uses. In general it is possible to discern two different interpretation methods. One the one hand a teleological interpretation, the intent underlying the patent is most important, to ensure that the individual rights of the patentee are protected as much as possible. On the other hand a grammatical interpretation, the text of the patent application is most important, to ensure that the rights of third parties are protected as much as possible. In Europe, German courts tend to make use of a more teleological interpretation, whereas British courts tend to make use of a more grammatical interpretation. Because of these differences in interpretation, the European Patent Convention contains an "interpretation" protocol for those situations where it is not clear what is and what is not protected under patent.
United States
In the United States, the duration of a patent is:[2]
- 17 years for patents issued before June 8, 1995
- 20 years for patents issued after June 8, 1995
Patent term extensions
Patents for products such as food additives and drugs that require approval by federal entities such as the US Food and Drug Administration prior to marketing, can have a maximum of 5 years extended to the patent to compensate for marketing time lost while waiting for approval."[3] In all cases, the total patent life for the product with the patent extension cannot exceed 14 years from the product’s approval date, or in other words, 14 years of potential marketing time. "[2][4]
Forms of patent infringement
A patent infringement can take two forms, either a direct or an indirect infringement. If the exact same (production) procedure is used this constitutes a direct patent infringement. Which means if a company other than Philips were to produce a “Senseo” coffee machine that company would be directly infringing on Philips' patent. However if a part of a patented invention is produced this can constitute an indirect patent infringement. If for instance companies other than those licensed by Philips were to produce coffee pads for the “Senseo” machine that company could be indirectly infringing on Philips' patent.
Controversy
There is controversy as to whether patents impede medical research.[5]
References
- ↑ Kesselheim AS (2009). "The Supreme Court, Process Patents, and Medical Innovation.". N Engl J Med. DOI:10.1056/NEJMp0909658. PMID 19923562. Research Blogging.
- ↑ 2.0 2.1 Anonymous (09/20/2010 8). Frequently Asked Questions on Patents and Exclusivity. US Food and Drug Administration. Retrieved on 2011-02-20.
- ↑ [https://www.uspto.gov/web/offices/pac/mpep/s2750.html MPEP 2750 Patent Term Extension for Delays at other Agencies under 35 U.S.C. 156
- ↑ Nightingale, S (August 1, 1991). Statement by Stuart Nightingale, M.D. Associate Commissioner For Health Affairs U.S. Food and Drug Administration Public Health Service Department Of Health And Human Services Before the Subcommittee on Patents, Copyrights and Trademarks Committee on the Judiciary United States Senate. US Food and Drug Administration. Retrieved on 2009-01-11.
- ↑ Gold ER, Kaplan W, Orbinski J, Harland-Logan S, N-Marandi S (2010). "Are patents impeding medical care and innovation?". PLoS Med 7 (1): e1000208. DOI:10.1371/journal.pmed.1000208. PMID 20052274. Research Blogging.